Dashboard
Manage Tickers

GKOS GLAUKOS Corp

NYSE glaukos.com


$ 82.38 $ -1.85 (-2.21 %)    

Thursday, 06-Nov-2025 15:08:47 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 615.00 $ -6.87 (-1.1 %)
DIA $ 470.25 $ -1.78 (-0.38 %)
SPY $ 672.77 $ -3.70 (-0.55 %)
TLT $ 89.69 $ 0.14 (0.15 %)
GLD $ 366.60 $ -0.61 (-0.17 %)
$ 84.35
$ 83.00
$ 82.21 x 94
$ 82.48 x 1
$ 81.81 - $ 83.00
$ 73.16 - $ 163.71
691,823
na
4.84B
$ 1.11
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-30-2025 09-30-2025 10-Q
2 08-04-2025 06-30-2025 10-Q
3 05-01-2025 03-31-2025 10-Q
4 02-24-2025 12-31-2024 10-K
5 11-04-2024 09-30-2024 10-Q
6 08-02-2024 06-30-2024 10-Q
7 05-02-2024 03-31-2024 10-Q
8 02-23-2024 12-31-2023 10-K
9 11-01-2023 09-30-2023 10-Q
10 08-02-2023 06-30-2023 10-Q
11 05-04-2023 03-31-2023 10-Q
12 02-24-2023 12-31-2022 10-K
13 11-04-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 02-28-2022 12-31-2021 10-K
17 11-08-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 03-01-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 08-10-2020 06-30-2020 10-Q
23 05-07-2020 03-31-2020 10-Q
24 03-02-2020 12-31-2019 10-K
25 11-06-2019 09-30-2019 10-Q
26 08-08-2019 06-30-2019 10-Q
27 05-08-2019 03-31-2019 10-Q
28 02-28-2019 12-31-2018 10-K
29 11-07-2018 09-30-2018 10-Q
30 08-06-2018 06-30-2018 10-Q
31 05-09-2018 03-31-2018 10-Q
32 02-28-2018 12-31-2017 10-K
33 11-08-2017 09-30-2017 10-Q
34 08-07-2017 06-30-2017 10-Q
35 05-04-2017 03-31-2017 10-Q
36 03-15-2017 12-31-2016 10-K
37 11-14-2016 09-30-2016 10-Q
38 08-04-2016 06-30-2016 10-Q
39 05-04-2016 03-31-2016 10-Q
40 03-15-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jp-morgan-maintains-overweight-on-glaukos-raises-price-target-to-120
JP Morgan Maintains Overweight on Glaukos,...
10/30/2025 20:59:15

JP Morgan analyst Allen Gong maintains Glaukos (NYSE:GKOS) with a Overweight and raises the price target from $110 to $120.

citigroup-maintains-buy-on-glaukos-raises-price-target-to-113
Citigroup Maintains Buy on Glaukos, Raises...
10/30/2025 18:39:35

Citigroup analyst Joanne Wuensch maintains Glaukos (NYSE:GKOS) with a Buy and raises the price target from $110 to $113.

wells-fargo-maintains-overweight-on-glaukos-raises-price-target-to-122
Wells Fargo Maintains Overweight on Glauko...
10/30/2025 14:39:09

Wells Fargo analyst Larry Biegelsen maintains Glaukos (NYSE:GKOS) with a Overweight and raises the price target from $120 to...

cardinal-health-posts-upbeat-q1-results-joins-guardant-health-glaukos-ch-robinson-and-other-big-stocks-moving-higher-on-thursday
Cardinal Health Posts Upbeat Q1 Results, J...
10/30/2025 14:19:43

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/30/2025 12:08:54

alphabet-to-rally-around-22-here-are-10-top-analyst-forecasts-for-thursday
Alphabet To Rally Around 22%? Here Are 10 ...
10/30/2025 11:36:08

needham-maintains-buy-on-glaukos-raises-price-target-to-117
Needham Maintains Buy on Glaukos, Raises P...
10/30/2025 11:27:37

Needham analyst David Saxon maintains Glaukos (NYSE:GKOS) with a Buy and raises the price target from $115 to $117.

btig-maintains-buy-on-glaukos-raises-price-target-to-116
BTIG Maintains Buy on Glaukos, Raises Pric...
10/30/2025 10:26:32

BTIG analyst Ryan Zimmerman maintains Glaukos (NYSE:GKOS) with a Buy and raises the price target from $104 to $116.

why-alphabet-shares-are-trading-higher-by-around-8-here-are-20-stocks-moving-premarket
Why Alphabet Shares Are Trading Higher By ...
10/30/2025 09:38:55

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/29/2025 21:06:30

glaukos-raises-fy2025-sales-guidance-from-480000m-486000m-to-490000m-495000m-vs-484630m-est
Glaukos Raises FY2025 Sales Guidance from ...
10/29/2025 20:07:23

Glaukos (NYSE:GKOS) raises FY2025 sales outlook from $480.000 million-$486.000 million to $490.000 million-$495.000 million vs ...

glaukos-q3-adj-eps-016-beats-026-estimate-sales-133537m-beat-122540m-estimate
Glaukos Q3 Adj. EPS $(0.16) Beats $(0.26) ...
10/29/2025 20:06:50

Glaukos (NYSE:GKOS) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.26) by 37.9...

earnings-scheduled-for-october-29-2025
Earnings Scheduled For October 29, 2025
10/29/2025 11:11:56

booking-holdings-to-rally-around-12-here-are-10-top-analyst-forecasts-for-monday
Booking Holdings To Rally Around 12%? Here...
10/27/2025 12:00:54

this-five-below-analyst-turns-bullish-here-are-top-5-upgrades-for-monday
This Five Below Analyst Turns Bullish; Her...
10/27/2025 11:29:57

wells-fargo-upgrades-glaukos-to-overweight-raises-price-target-to-120
Wells Fargo Upgrades Glaukos to Overweight...
10/27/2025 11:16:07

Wells Fargo analyst Larry Biegelsen upgrades Glaukos (NYSE:GKOS) from Equal-Weight to Overweight and raises the price target...

btig-reiterates-buy-on-glaukos-maintains-104-price-target
BTIG Reiterates Buy on Glaukos, Maintains ...
10/20/2025 12:27:35

BTIG analyst Ryan Zimmerman reiterates Glaukos (NYSE:GKOS) with a Buy and maintains $104 price target.

the-fda-approves-glaukos-epioxa-hdepioxa-as-first-incision-free-topical-drug-therapy-for-keratoconus-epioxa-is-expected-to-be-commercially-available-in-q1-2026
The FDA Approves Glaukos' Epioxa HD/Epioxa...
10/20/2025 11:04:58

expert-outlook-glaukos-through-the-eyes-of-7-analysts
Expert Outlook: Glaukos Through The Eyes O...
10/13/2025 14:00:44

btig-maintains-buy-on-glaukos-lowers-price-target-to-104
BTIG Maintains Buy on Glaukos, Lowers Pric...
10/13/2025 12:07:45

BTIG analyst Ryan Zimmerman maintains Glaukos (NYSE:GKOS) with a Buy and lowers the price target from $118 to $104.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION